Georgi P.
- Country
- Bulgaria
- Department
- II Psychiatric Clinic
Research Overview
- Evaluation of Safety, Pharmacokinetics, and Efficacy of GS-5245 in Pediatric Patients with COVID-19: A Phase 2/3 Single-Arm, Open-Label Study
- Evaluation of EDP-938 (Zelicapavir) Efficacy and Safety in Non-Hospitalized Adults with Acute Respiratory Syncytial Virus Infection at High Risk for Complications
- Efficacy and Tolerability of BH-200 (Nelivaptan) in V1b-High Outpatients with Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
Data & Insights
Has run more than one trial at 1 of 91 partner sites.
Specializations
Infectious Diseases and Viral Hepatitis
Clinical work is centered on infectious diseases with a strong focus on chronic hepatitis B, hepatitis delta, and COVID-19. The research portfolio also includes respiratory and urinary infections, reflecting interest in both persistent viral disease and acute antimicrobial therapy.
- Chronic hepatitis B
- Chronic hepatitis delta
- COVID-19
- Complicated urinary tract infection
- Acute pyelonephritis
Therapeutic interest extends to functional cure strategies in chronic hepatitis and to treatment options for infections in hospitalized and pediatric settings.
Oncology and Hematologic Malignancies
The investigator is active in a broad range of oncology studies, including non-small cell lung cancer, urothelial cancer, prostate cancer, breast cancer, ovarian cancer, and colorectal cancer. Hematologic interests include chronic lymphocytic leukemia, multiple myeloma, non-Hodgkin lymphoma, and myelodysplastic syndrome.
- Non-small cell lung cancer
- Urothelial cancer
- Prostate cancer
- Breast cancer
- Hematologic malignancies
Research activity also covers tumor-directed combinations and biomarker-driven treatment approaches in advanced solid tumors and blood cancers.
Cardiometabolic and Renal Disorders
Another major area of interest is cardiometabolic disease, including acute myocardial infarction, heart failure, type 2 diabetes, obesity, chronic kidney disease, and hypertriglyceridemia. The portfolio also includes non-alcoholic steatohepatitis and related metabolic liver disease.
- Acute myocardial infarction
- Heart failure
- Type 2 diabetes
- Chronic kidney disease
- Hypertriglyceridemia
Therapeutic emphasis includes cardiovascular risk reduction, metabolic control, and organ-protective strategies across liver, kidney, and heart disease.
Autoimmune, Endocrine, and Immune-Mediated Conditions
Clinical research also spans systemic lupus erythematosus, primary immune thrombocytopenia, Graves’ disease, and ulcerative colitis. These studies place the investigator within immune-mediated disease management across rheumatology, hematology, endocrinology, and gastroenterology.
- Systemic lupus erythematosus
- Primary immune thrombocytopenia
- Graves’ disease
- Ulcerative colitis
- Immune-mediated inflammatory disease
Therapeutic interests include disease control, immune modulation, and restoration of endocrine and hematologic stability.
Respiratory, Neurologic, and Supportive Care Therapies
The investigator’s portfolio includes respiratory syncytial virus, small-cell lung cancer, major depressive disorder, and postoperative pain, showing involvement in both disease-modifying and symptomatic treatment areas. Additional interest is seen in supportive care for cancer-related weight loss and appetite-related symptoms.
- Respiratory syncytial virus
- Small-cell lung cancer
- Major depressive disorder
- Postoperative pain
- Cancer cachexia
These activities reflect therapeutic attention to infection control, symptom relief, and quality-of-life issues alongside specialty disease treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.